4D Molecular CEO Kirn sells 58,333 shares
4D Molecular Therapeutics Chief Executive Officer David Kirn sold 58,333 shares at $12.92 each, according to a Form 4 filing. The transaction was indicated as part of a 10b5-1 plan.
4D Molecular Therapeutics Chief Executive Officer David Kirn sold 58,333 shares at $12.92 each, according to a Form 4 filing. The transaction was indicated as part of a 10b5-1 plan.